In the early stages of cancer, a small quantity of biomarkers would release from the tumor into the blood, which indicates the presence and classification of the tumor, for example, the alpha fetal protein (AFP), prostate-specific antigen (PSA), and carcinoembryonic antigen (CEA)-related cell adhesion molecules 5 (CEACAM5). Here, CEACAM5 is linked to neoplasm.